Navigation Links
Jackee Harry - Star of TV, Film and Theatre – New GBG Spokesperson
Date:4/2/2010

GBG is very excited and proud to have Ms. Harry representing us and promoting our everlasting theme of LIFE, HEALTH, and WEALTH!

(PRWEB) April 2, 2010 -- GBG proudly announced today the addition of Jackee Harry, star of TV, movies and theatre, as an official Spokesperson. Ms. Harry, who won an Emmy for her role as Sandra Clark on the hit TV series, 227, has teamed up with GBG, a national Health & Wellness company, with corporate offices in Vacaville, Ca. to promote improved health and wealth across America.

Ms. Harry has extensive experience in theatre, daytime television, primetime television, movies, and has even loaned her voice to animated films. She has done it all. Ms. Harry recently wrapped the final season of CW’s “Everybody Hates Chris” and has been touring the country with J.D. Lawrence’s production of “The Cleanup Woman,” which is being developed into a feature film and TV series. Because of her international exposure, Ms. Harry’s alliance with GBG will help promote the mutual goal of improving the life, health and wealth of families across the nation….and beyond.

In addition to her acting career, Ms. Harry has consistently been active in a variety of philanthropic endeavors, including this year’s “Trump AIDS” initiative, which she co-chaired with Danny Glover. While working with GBG, Ms. Harry will expand her big-hearted giving ways, coordinating with a variety of national organizations.

GBG is a fast-growing company, but is not a large conglomerate – nor do they have hundreds of products in their line. GBG is a privately owned company, located in the pure, open grasslands of beautiful Northern California. Their lead product is the exclusive GBG 10-in-One Liquid Multi-Vitamin and Mineral Super Formula, which is literally 10 Formulas in one. GBG’s focus on this superb form
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Researchers at Meharry Medical College Find Green Tea Extract Showing Promise for Treatment of Uterine Fibroids
2. The Leona M. and Harry B. Helmsley Charitable Trust Donates $3 Million to Haitian Relief Efforts
3. Meharry Medical College Officer Will Head the National Dental Association
4. Black Activists Condemn Senate Leader Harry Reid Playing the Race Card in Health Care Debate
5. Meharry-State Farm Alliance to Recognize Florida Legislators for Seat Belt Law
6. Worlds #1 Health Brand for Kids Joins Forces With Worlds #1 In-School Childrens Theatre
7. HD For More Than Your TV – New Technologies Offer Patients High Definition Vision At Any Age
8. The Institute of Women's Health of North America to Offer Free Chlamydia Testing at All Affiliated Campuses – Dr. Abdul Rao
9. Mamabears.com Launches Stroller Signs – Finally a Kind Way to Say Do Not Touch
10. A World-Class HR Master's Degree Is Now Within Reach – 100% Online
11. Health: Surprise Best Seller is Stem Cell Book – Author in Spokane - 10 City Tour
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Jackee Harry - Star of TV, Film and Theatre – New GBG Spokesperson
(Date:3/3/2015)... 2015 The FSH Society , ... the little-known and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), ... . The purpose of the campaign is to spread ... most common forms of muscular dystrophies. , To ... the FSH Society will begin sharing impactful photographs of ...
(Date:3/3/2015)... Presale tickets for Madonna will be ready for purchase ... March 9, with Madonna tour tickets expected to sell out ... talented artist is a significant one for fans, and the ... Ticketability.com to browse the inventory of Madonna tickets at ... enjoy, the 2015 tour is expected to attract attention from ...
(Date:3/3/2015)... 2015 State after state prove ... of probation programs aimed to rehabilitate nonviolent drug ... (tax) cost of incarcerating violators of drug laws, ... alcohol addiction treatment. Governor Bruce Rauner ( R)has ... Illinois' drug and alcohol statewide Department of Alcoholism ...
(Date:3/3/2015)... Using an “intelligent,” rather than random, method ... prescription drug coverage plans could save Medicare and patients ... Pittsburgh Graduate School of Public Health analysis discovered. ... of the journal Health Affairs and build upon an ... than $5 billion in its Part D low-income subsidy ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Volpara Solutions, ... announced that John D. Pavlidis has joined their Board ... of technical and executive management experience in the medical ... large and small organizations. , “John’s broad management experience ... imaging modalities will be a tremendous asset to the ...
Breaking Medicine News(10 mins):Health News:Share to be Aware: FSH Society Launches #CureFSHD Campaign 2Health News:Share to be Aware: FSH Society Launches #CureFSHD Campaign 3Health News:Presale Tickets for Madonna: Ticketability.com Announces Madonna Tour Tickets for Sale at Reduced Prices for the Rebel Heart Tour During Presales 2Health News:Gov. of Illinois, Bruce Rauner, Suggests Cutting 25 Million for Drug Rehabilitation, Harbor Village Comments 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:Volpara Solutions Adds Medical Imaging Veteran John Pavlidis to Board of Directors 2Health News:Volpara Solutions Adds Medical Imaging Veteran John Pavlidis to Board of Directors 3
... numbers are staggering --,over 20% of people living in ... the impairment or disability which creates dependency and,poverty in ... and political opportunities," says Ron Nabors, Chief,Executive Officer of ... stand up and speak out on the,International Day for ...
... Oct. 16 Children in the South Bay,suffering ... conditions can,now receive specialty care from Lucile Packard ... hospital,s new South Bay,Specialty Center in Los Gatos ... all the hallmarks of its parent institution. ...
... WEST CHESTER, Ohio, Oct. 16 AtriCure, Inc.,(Nasdaq: ... leader in cardiac surgical,ablation products, today announced that ... which physicians have adopted to,treat atrial fibrillation (AF), ... Dr. James H. McClelland, an,electrophysiologist, and colleagues from ...
... the U.S. Food and Drug,Administration,s (FDA,s) Cardiovascular ... majority of members voted to recommend the ... FOSRENOL(R),(lanthanum carbonate), to treat hyperphosphatemia (elevated levels ... disease (CKD) Stage 4 patients.,Currently, FOSRENOL is ...
... and Advertising ... Distribution Agreements, WebMD Announces Third Quarter Earnings ... WebMD Health Corp. (Nasdaq:,WBMD), the leading provider of health information services, ... Preliminary Results for the Three Months Ended September 30, 2007 ...
... Oct. 16 HLTH Corporation,(Nasdaq: HLTH ) today ... months ended September 30, 2007 at approximately 4:00 pm ... previously announced, HLTH Corporation,s 84% owned,subsidiary, WebMD Health Corp. ... their financial results for the three months ended September ...
Cached Medicine News:Health News:CBM USA stands up and speaks out to world leaders on the International Day for the Eradication of Poverty 2Health News:Packard Children's Hospital Opens New South Bay Specialty Clinic Bringing Specialty Care Close to Home 2Health News:Published Results Using AtriCure Minimally Invasive Products 2Health News:Published Results Using AtriCure Minimally Invasive Products 3Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 2Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 3Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 4Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 5Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 6Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 7Health News:WebMD Reports Preliminary Third Quarter Financial Results 2Health News:WebMD Reports Preliminary Third Quarter Financial Results 3Health News:WebMD Reports Preliminary Third Quarter Financial Results 4Health News:WebMD Reports Preliminary Third Quarter Financial Results 5Health News:WebMD Reports Preliminary Third Quarter Financial Results 6Health News:WebMD Reports Preliminary Third Quarter Financial Results 7Health News:WebMD Reports Preliminary Third Quarter Financial Results 8Health News:WebMD Reports Preliminary Third Quarter Financial Results 9Health News:WebMD Reports Preliminary Third Quarter Financial Results 10Health News:WebMD Reports Preliminary Third Quarter Financial Results 11Health News:HLTH Corporation Announces Third Quarter Earnings Release Date and Conference Call 2
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research and ... addition of Jain PharmaBiotech,s new report "Cardiovascular Drug ... offering. , Drug delivery to the ... because of the anatomy and physiology of the vascular ... of the body. Drugs can be introduced into the ...
(Date:3/3/2015)... 2015  Delcath Systems, Inc. (NASDAQ: ... company focused on oncology with an emphasis on ... announces that the results from its Phase 3 ... been submitted for publication in a leading peer-reviewed ... for Injection for use with the Delcath Hepatic ...
(Date:3/3/2015)... Depomed, Inc. (NASDAQ: DEPO ) today ... Annual Roth Conference in Laguna Niguel ... (9:30 am PT) Tuesday, March 10, 2015. The ... via the Investor Relations page of the Depomed website at ... archived for 30 days on the company,s website. ...
Breaking Medicine Technology:Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 2Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 2Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 4Depomed To Present At 27th Annual Roth Conference 2
... control ... with combination therapy -, ... study presents,data demonstrating that patients with Chronic Obstructive Pulmonary ... and symptom control when treated with a,combination of nebulized ...
... Presented at the 2008 International Conference of the American ... ... May 20 Forest Laboratories, Inc. and,Laboratorios Almirall, S.A. today ... of aclidinium bromide, an,investigational treatment for chronic obstructive pulmonary disease ...
Cached Medicine Technology:Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 2Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 3Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 4Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 5Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 6Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 7Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 2Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 3Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 4Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 5
The STAAR ELASTIMIDE™ lens, combines the best of foldable lens technology with traditional design. This lens contains a cast-molded, silicone optic with modified Polyimide haptics....
The STAAR ELASTIC LENS®, is a single piece silicone lens to be placed completely in the capsular bag....
Foldable Silicone Multi-piece Lens....
... Lomb UV-Absorbing, Silicone Posterior Chamber Intraocular Lens ... for the visual correction of aphakia in ... in whom the cataractous lens has been ... device is intended to be placed only ...
Medicine Products: